ClearBridge Investments - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 172 filers reported holding BLUEBIRD BIO INC in Q4 2014. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
ClearBridge Investments ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2020$22,000
-47.6%
362
-60.1%
0.00%
Q1 2020$42,000
-26.3%
908
+36.7%
0.00%
Q4 2019$57,000
-45.2%
664
-41.2%
0.00%
Q3 2019$104,000
-27.8%
1,1290.0%0.00%
Q2 2019$144,000
+9.1%
1,129
+34.6%
0.00%
Q1 2019$132,000
+88.6%
839
+18.2%
0.00%
Q4 2018$70,000
-32.7%
7100.0%0.00%
Q3 2018$104,000
-6.3%
7100.0%0.00%
Q2 2018$111,000
-26.5%
710
-19.6%
0.00%
Q1 2018$151,000
-3.8%
8830.0%0.00%
Q4 2017$157,000
+13.8%
883
-12.2%
0.00%
Q3 2017$138,000
+30.2%
1,0060.0%0.00%
Q2 2017$106,000
+17.8%
1,006
+1.7%
0.00%
Q1 2017$90,000
+47.5%
9890.0%0.00%
Q4 2016$61,000
-7.6%
989
+1.7%
0.00%
Q3 2016$66,000
+57.1%
9720.0%0.00%
Q2 2016$42,000
+27.3%
972
+25.6%
0.00%
Q1 2016$33,000
-26.7%
774
+11.4%
0.00%
Q4 2015$45,000
-10.0%
695
+18.8%
0.00%
Q3 2015$50,000
-58.0%
585
-17.4%
0.00%
Q2 2015$119,000
+466.7%
708
+309.2%
0.00%
Q1 2015$21,000
-30.0%
173
-46.4%
0.00%
Q4 2014$30,000
+150.0%
3230.0%0.00%
Q3 2014$12,0000.0%3230.0%0.00%
Q2 2014$12,000
+71.4%
323
+3.2%
0.00%
Q1 2014$7,000
+40.0%
313
+36.1%
0.00%
Q4 2013$5,000
-16.7%
2300.0%0.00%
Q3 2013$6,0002300.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2014
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders